Common Contracts
2 similar Execution Version contracts by Alnylam Pharmaceuticals, Inc., Clovis Oncology, Inc.
ALNYLAM PHARMACEUTICALS, INC. 5,000,000 Shares of Common Stock Underwriting AgreementExecution Version • January 15th, 2019 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Alnylam Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule I hereto (the “Underwriters”), for whom Barclays Capital Inc. is acting as representative (the “Representative”), an aggregate of 5,000,000 shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 750,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”. To the extent there are no additional Underwriters listed in Schedule I hereto, all references herein to the Underwriters shall refer just to you.
CLOVIS ONCOLOGY, INC. 5,000,000 Shares of Common Stock (par value $0.001 per share) Underwriting AgreementExecution Version • January 9th, 2017 • Clovis Oncology, Inc. • Pharmaceutical preparations • New York
